First Time Loading...

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 34.2 CNY -0.64% Market Closed
Updated: May 16, 2024
China Resources Boya Bio pharmaceutical Group Co Ltd
/
Income Statement
/
Interest Income Expense

China Resources Boya Bio pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Resources Boya Bio pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Interest Income Expense
¥114m
CAGR 3-Years
96%
CAGR 5-Years
83%
CAGR 10-Years
21%
Beigene Ltd
HKEX:6160
Interest Income Expense
-¥59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
¥445.8m
CAGR 3-Years
N/A
CAGR 5-Years
84%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
¥217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-¥33.6m
CAGR 3-Years
38%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
¥100.8m
CAGR 3-Years
126%
CAGR 5-Years
96%
CAGR 10-Years
N/A

See Also

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
114m CNY

Based on the financial report for Mar 31, 2024, China Resources Boya Bio pharmaceutical Group Co Ltd's Interest Income Expense amounts to 114m CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
21%

Over the last year, the Interest Income Expense growth was -1%. The average annual Interest Income Expense growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been 96% over the past three years , 83% over the past five years , and 21% over the past ten years .

ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.